Adaptimmune Therapeutics is Other Commercial Services in United Kingdom that focus on Adaptimmune Therapeutics PLC business. Founded in 2008. They cover business area such as Adaptimmune Therapeutics PLC, novel cell therapy, patient, solid tumor, cancer target, TCR therapeutic candidate, administration, its program, NON-small cell lung CANCER, AFP spear t-cell, ny-eso spear t-cell, multiple cancer type.
2008
( 16 years old in 2024 )
Adaptimmune Therapeutics PLC
-
60 Jubilee Avenue
Milton Park
Abingdon OX14 4RX
England, United Kingdom
Private
Adaptimmune Therapeutics PLCnovel cell therapypatientsolid tumorcancer targetTCR therapeutic candidateadministrationits programNON-small cell lung CANCERAFP spear t-cellny-eso spear t-cellmultiple cancer type
* We use standard office opening hours in near Adaptimmune Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Adaptimmune Therapeutics is Other Commercial Services business from United Kingdom that founded in 2008 (16 years old in 2024), Adaptimmune Therapeutics business is focusing on Adaptimmune Therapeutics PLC.
Adaptimmune Therapeutics headquarter office and corporate office address is located in 60 Jubilee Avenue Milton Park Abingdon OX14 4RX England, United Kingdom.
Adaptimmune Therapeutics was founded in United Kingdom.
In 2024, Adaptimmune Therapeutics is currently focus on Adaptimmune Therapeutics PLC sector.
Above is snippet of Google Trends for "Adaptimmune Therapeutics PLC" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Adaptimmune Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
